Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Carcinoma, Non-Small-Cell Lung 31 Melanoma 20 Neoplasms 13 Breast Neoplasms 11 Pancreatic Neoplasms 9 Lung Neoplasms 9 Head and Neck Neoplasms 9 Triple Negative Breast Neoplasms 8 Stomach Neoplasms 8 Squamous Cell Carcinoma of Head and Neck 8 Ovarian Neoplasms 8 Neoplasm Metastasis 8 Colorectal Neoplasms 7 Carcinoma, Renal Cell 7 Carcinoma, Hepatocellular 6 Prostatic Neoplasms 4 Hodgkin Disease 4 Glioblastoma 4 Carcinoma, Transitional Cell 4 Carcinoma 4 Uterine Cervical Neoplasms 3 Liver Neoplasms 3 Kidney Neoplasms 3 Esophageal Squamous Cell Carcinoma 3 Esophageal Neoplasms 3 Adenocarcinoma 3 Small Cell Lung Carcinoma 2 Parkinson Disease 4, Autosomal Dominant Lewy Body 2 Neoplasms, Squamous Cell 2 Mesothelioma 2

Interventions

Oxaliplatin 5 Irinotecan 5 Panitumumab 4 Capecitabine 4 Bevacizumab 4 Cetuximab 3 Leucovorin 2 Fluorouracil 2 trifluridine tipiracil drug combination 1 spartalizumab 1 regorafenib 1 raltitrexed 1 pembrolizumab 1 camrelizumab 1 aflibercept 1 XELOX 1 Radiotherapy 1 Radiosurgery 1 Lycopene 1 Loperamide 1 Ethiodized Oil 1 Drug Therapy 1 Cytoreduction Surgical Procedures 1 Antineoplastic Agents 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Unknown × Colorectal Cancer Metastatic × pembrolizumab × Clear all

NCT04262687 2023-08-18

POCHI

Federation Francophone de Cancerologie Digestive

Phase 2 Unknown

Gastrointestinal

Colorectal Cancer Metastatic

Data powered by HemOnc (CC BY 4.0) Colophon ⚡